JP2023538393A5 - - Google Patents

Info

Publication number
JP2023538393A5
JP2023538393A5 JP2023512226A JP2023512226A JP2023538393A5 JP 2023538393 A5 JP2023538393 A5 JP 2023538393A5 JP 2023512226 A JP2023512226 A JP 2023512226A JP 2023512226 A JP2023512226 A JP 2023512226A JP 2023538393 A5 JP2023538393 A5 JP 2023538393A5
Authority
JP
Japan
Prior art keywords
phenyl
methylsulfonyl
pyridine
imidazo
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023512226A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023538393A (ja
JP7813775B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/046420 external-priority patent/WO2022040259A1/en
Publication of JP2023538393A publication Critical patent/JP2023538393A/ja
Publication of JP2023538393A5 publication Critical patent/JP2023538393A5/ja
Application granted granted Critical
Publication of JP7813775B2 publication Critical patent/JP7813775B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023512226A 2020-08-19 2021-08-18 線維症の処置のためのtlr9の阻害剤としてのイミダゾ[1,2-a]ピリジンおよび[1,2,4]トリアゾロ[1,5-a]ピリジン誘導体 Active JP7813775B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063067452P 2020-08-19 2020-08-19
US63/067,452 2020-08-19
PCT/US2021/046420 WO2022040259A1 (en) 2020-08-19 2021-08-18 Imidazo[1,2-a]pyridine and [1,2,4]triazolo[1,5-a]pyridine derivatives as tlr9 inhibitors for the treatment of fibrosis

Publications (3)

Publication Number Publication Date
JP2023538393A JP2023538393A (ja) 2023-09-07
JP2023538393A5 true JP2023538393A5 (enExample) 2024-08-26
JP7813775B2 JP7813775B2 (ja) 2026-02-13

Family

ID=77693624

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023512226A Active JP7813775B2 (ja) 2020-08-19 2021-08-18 線維症の処置のためのtlr9の阻害剤としてのイミダゾ[1,2-a]ピリジンおよび[1,2,4]トリアゾロ[1,5-a]ピリジン誘導体

Country Status (13)

Country Link
US (1) US12486267B2 (enExample)
EP (1) EP4200297B1 (enExample)
JP (1) JP7813775B2 (enExample)
KR (1) KR20230053644A (enExample)
CN (1) CN116096717B (enExample)
AR (1) AR123281A1 (enExample)
AU (1) AU2021328575A1 (enExample)
BR (1) BR112023002737A2 (enExample)
CA (1) CA3190065A1 (enExample)
IL (1) IL300727A (enExample)
MX (1) MX2023001885A (enExample)
TW (1) TW202227432A (enExample)
WO (1) WO2022040259A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11807622B2 (en) 2019-01-30 2023-11-07 Insilico Medicine Ip Limited TLR 9 inhibitors
EP4479407A1 (en) * 2022-02-18 2024-12-25 Bristol-Myers Squibb Company Substituted bicyclic heteroaryl compounds useful as inhibitors of tlr9
CN120230100B (zh) * 2025-05-30 2025-09-05 中国药科大学 一种咪唑并[1,2-a]吡嗪或咪唑并[1,2-a]吡啶类化合物及其医药用途

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060235037A1 (en) 2005-04-15 2006-10-19 Purandare Ashok V Heterocyclic inhibitors of protein arginine methyl transferases
GB0602178D0 (en) 2006-02-03 2006-03-15 Merck Sharp & Dohme Therapeutic treatment
JP2009532501A (ja) 2006-04-04 2009-09-10 ミリアド ジェネティクス, インコーポレイテッド 疾患および障害のための化合物
US20100035756A1 (en) 2006-07-12 2010-02-11 Syngenta Limited Triazolophyridine derivatives as herbicides
US20100197657A1 (en) 2007-09-25 2010-08-05 Chang Ronald K 2-aryl or heteroaryl indole derivatives
US8785489B2 (en) 2008-10-17 2014-07-22 Boehringer Ingelheim International Gmbh Heteroaryl substituted indole compounds useful as MMP-13 inhibitors
RU2012116207A (ru) 2009-09-24 2013-10-27 Ф.Хоффманн-Ля Рош Аг Производные индола в качестве модуляторов crac
TWI617559B (zh) 2010-12-22 2018-03-11 江蘇恆瑞醫藥股份有限公司 2-芳基咪唑并[1,2-b]嗒.2-苯基咪唑并[1,2-a]吡啶,和2-苯基咪唑并[1,2-a]吡衍生物
US9193724B2 (en) 2011-09-22 2015-11-24 Merck Sharp & Dohme Corp. Triazolopyridyl compounds as aldosterone synthase inhibitors
US20130158049A1 (en) 2011-12-20 2013-06-20 Hoffmann-La Roche Inc. 7-azaindole inhibitors of crac
US20130158066A1 (en) 2011-12-20 2013-06-20 Hoffmann-La Roche Inc. 4-azaindole inhibitors of crac
WO2013156431A1 (en) 2012-04-17 2013-10-24 Syngenta Participations Ag Pesticidally active pyridyl- and pyrimidyl- substituted thiazole and thiadiazole derivatives
JP6168055B2 (ja) 2012-06-18 2017-07-26 住友化学株式会社 縮合複素環化合物
CA2933466A1 (en) 2013-12-13 2015-06-18 Takeda Pharmaceutical Company Limited Pyrrolo[3,2-c]pyridine derivatives as tlr inhibitors
JP6695865B2 (ja) * 2014-09-16 2020-05-20 シンジェンタ パーティシペーションズ アーゲー 硫黄含有置換基を有する有害生物防除に活性である四環式誘導体
BR112018006005A2 (pt) * 2015-09-29 2018-10-30 Oncotherapy Science Inc composto bicíclico e uso do mesmo para inibição de suv39h2
US10071079B2 (en) 2016-06-29 2018-09-11 Bristol-Myers Squibb Company [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
MX391344B (es) 2016-07-30 2025-03-21 Bristol Myers Squibb Co Compuestos indol sustituidos con dimetoxifenilo como inhibidores de receptores tipo toll 7, 8 o 9 (tlr7, tlr8 o tlr9).
JP7028861B2 (ja) 2016-09-09 2022-03-02 ブリストル-マイヤーズ スクイブ カンパニー ピリジル置換のインドール化合物
EP3538513A1 (en) * 2016-11-11 2019-09-18 Dynavax Technologies Corporation Toll-like receptor antagonist compounds and methods of use
WO2018165112A1 (en) * 2017-03-09 2018-09-13 Oncotherapy Science, Inc. Bicyclic compound and use thereof for inhibiting histone methyltransferase
ES2921020T3 (es) 2017-08-04 2022-08-16 Bristol Myers Squibb Co Compuestos de indol sustituidos con [1,2,4]triazolo[4,3-a]piridinilo
CN110997656B (zh) 2017-08-04 2023-04-14 百时美施贵宝公司 用作tlr7/8/9抑制剂的取代的吲哚化合物
WO2019099336A1 (en) * 2017-11-14 2019-05-23 Bristol-Myers Squibb Company Substituted indole compounds
AU2018386201A1 (en) 2017-12-15 2020-07-30 Bristol-Myers Squibb Company Substituted indole ether compounds
JP7289301B2 (ja) 2017-12-18 2023-06-09 ブリストル-マイヤーズ スクイブ カンパニー 4-アザインドール化合物
US11878975B2 (en) 2017-12-19 2024-01-23 Bristol-Myers Squibb Company Substituted indole compounds useful as TLR inhibitors
SG11202005704RA (en) 2017-12-19 2020-07-29 Bristol Myers Squibb Co 6-azaindole compounds
CN111511730B (zh) 2017-12-19 2023-07-25 百时美施贵宝公司 可用作tlr抑制剂的被酰胺取代的吲哚化合物
KR102730859B1 (ko) 2017-12-20 2024-11-15 브리스톨-마이어스 스큅 컴퍼니 아릴 및 헤테로아릴 치환된 인돌 화합물
SG11202005694RA (en) 2017-12-20 2020-07-29 Bristol Myers Squibb Co Amino indole compounds useful as tlr inhibitors
CA3085937A1 (en) 2017-12-20 2019-06-27 Bristol-Myers Squibb Company Diazaindole compounds
EP4089096A4 (en) * 2020-01-09 2024-01-03 Sumitomo Chemical Company, Limited HETEROCYCLIC COMPOUND AND MEANS THEREOF FOR CONTROLLING HARMFUL ARTHROPODS

Similar Documents

Publication Publication Date Title
US11197867B2 (en) Aminopyrimidinyl compounds
JP5656874B2 (ja) Pde9阻害剤として使用されるアミノヘテロ環化合物
JP4579346B2 (ja) アミノ複素環式化合物
JP4147184B2 (ja) 4−アミノ−6−フェニル−ピロロ[2,3−d]ピリミジン誘導体
IL310992A (en) NLRP3 inhibitors
JP2023525035A5 (enExample)
JP2023539136A5 (enExample)
JP2023538608A5 (enExample)
HRP20240994T1 (hr) Spoj inhibitora jak i njegova uporaba
JP2017535561A5 (enExample)
JP2021508686A5 (enExample)
US11254668B2 (en) Pyrazolo[1,5-A]pyrazin-4-yl and related derivatives
JP2018193405A (ja) Cotモジュレーターおよびその使用方法
JP2011509937A5 (enExample)
JP2011519891A5 (enExample)
JP2024536858A5 (enExample)
JP2021507895A5 (enExample)
RU2017121278A (ru) Триазоло-пиразинильные производные, применимые в качестве растворимых активаторов гуанилатциклазы
TW201321382A (zh) 化合物
JP2013508334A5 (enExample)
JP2019529443A5 (enExample)
JP2009507758A5 (enExample)
JP2016539146A5 (enExample)
JP2007526906A (ja) ピロロピリミジン誘導体
JP2019532052A5 (enExample)